Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa

por Mokgethi, Nomcebo Oratile, Christofides, Nicola, Machisa, Mercilene, Akpomiemie, Godspower, Lalla-Edward, Samantha
Publicado 2022

Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project

por Gomez, Gabriela B, Eakle, Robyn, Mbogua, Judie, Akpomiemie, Godspower, Venter, W D Francois, Rees, Helen
Publicado 2016

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz

por Griesel, Rulan, Maartens, Gary, Chirehwa, Maxwell, Sokhela, Simiso, Akpomiemie, Godspower, Moorhouse, Michelle, Venter, Francois, Sinxadi, Phumla
Publicado 2020

Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial

por Venter, Willem D. F., Majam, Mohammed, Akpomiemie, Godspower, Arulappan, Natasha, Moorhouse, Michelle, Mashabane, Nonkululeko, Chersich, Matthew F.
Publicado 2017

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy

por Griesel, Rulan, Kawuma, Aida N, Wasmann, Roeland, Sokhela, Simiso, Akpomiemie, Godspower, Venter, WD Francois, Wiesner, Lubbe, Denti, Paolo, Sinxadi, Phumla, Maartens, Gary
Publicado 2022

Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa

por Chandiwana, Nomathemba C., Chersich, Matthew, Venter, W.D. François, Akpomiemie, Godspower, Hill, Andrew, Simmons, Bryony, Lockman, Shahin, Serenata, Celicia M., Fairlie, Lee, Moorhouse, Michelle A.
Publicado 2021

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection

por Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony, Woods, Joana, Johnstone, Hilary, Akpomiemie, Godspower, Ellis, Leah, Owen, Andrew, Casas, Carmen Perez, Venter, Willem Daniel Francois
Publicado 2022

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

por Siedner, Mark J., Moorhouse, Michelle A., Simmons, Bryony, de Oliveira, Tulio, Lessells, Richard, Giandhari, Jennifer, Kemp, Stephen A., Chimukangara, Benjamin, Akpomiemie, Godspower, Serenata, Celicia M., Venter, Willem D. F., Hill, Andrew, Gupta, Ravindra K.
Publicado 2020

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials

por Tovar Sanchez, Tamara, Mpoudi-Etame, Mireille, Kouanfack, Charles, Delaporte, Eric, Calmy, Alexandra, Venter, Francois, Sokhela, Simiso, Bosch, Bronwyn, Akpomiemie, Godspower, Tembo, Angela, Pepperrell, Toby, Simmons, Bryony, Casas, Carmen Perez, McCann, Kaitlyn, Mirchandani, Manya, Hill, Andrew
Publicado 2023

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial

por Venter, Willem Daniel Francois, Kambugu, Andrew, Chersich, Matthew F., Becker, Stephen, Hill, Andrew, Arulappan, Natasha, Moorhouse, Michelle, Majam, Mohammed, Akpomiemie, Godspower, Sokhela, Simiso, Poongulali, Selvamuthu, Feldman, Charles, Duncombe, Chris, Ripin, David H. Brown, Vos, Alinda, Kumarasamy, Nagalingeswaran
Publicado 2019

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa

por Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony, Woods, Joana, Johnstone, Hilary, Madhi, Shabir, Qavi, Ambar, Ellis, Leah, Akpomiemie, Godspower, Bhaskar, Esther, Levi, Jacob, Falconer, Jonathan, Mirchandani, Manya, Perez Casas, Carmen, Moller, Karlien, Pilkington, Victoria, Pepperrell, Toby, Venter, Willem Daniel Francois
Publicado 2022